David Bardey, Arturo Harker, and Daniela Zuluaga, “Price cap regulation in the Colombian pharmaceutical market: An impact evaluation”, TSE Working Paper, n. 21-1195, March 2021.
David Bardey, Manuel Fernandez, and Alexis Gravel, “Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at least) in the Short Run?”, TSE Working Paper, n. 21-1189, February 2021.
David Bardey, and Philippe De Donder, “Welfare Impacts of Genetic Testing in Health Insurance Markets: Will Cross-Subsidies Survive?”, TSE Working Paper, n. 19-1035, September 2019.
David Bardey, Samuel Kembou Nzalé, and Bruno Ventelou, “Physicians’ incentives to adopt personalized medicine: experimental evidence”, TSE Working Paper, n. 18-968, November 2018.
David Bardey, Jorge Tovar, and Nicolas Santos, “Characterization of the relevant market in the media industry: some new evidence!”, TSE Working Paper, n. 16-719, October 2016.
David Bardey, and Giancarlo Buitrago, “Voluntary Health Plan Subsidies and Public Expenditure”, TSE Working Paper, n. 15-605, October 2015.
David Bardey, and Jean-Marc Bourgeon, “Health Care Network Formation and Policyholders' Welfare”, TSE Working Paper, n. 10-183, August 11, 2010.
E-mail : see the e-mail